Off-label use of rituximab in dermatology: pemphigus treatment

Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis. Nevertheless, over the past 14 years, many case reports have demonstrated the efficacy of off-label rituximab in seve...

Full description

Saved in:
Bibliographic Details
Main Authors: Lislaine Bomm (Author), Tainá Scalfoni Fracaroli (Author), João Luz Sodré (Author), Aline Bressan (Author), Alexandre Carlos Gripp (Author)
Format: Book
Published: Sociedade Brasileira de Dermatologia, 2013-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available